<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">anatomy</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал анатомии и гистопатологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Anatomy and Histopathology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-7357</issn><publisher><publisher-name>N.N. Burdenko Voronezh State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18499/2225-7357-2017-6-4-15-20</article-id><article-id custom-type="elpub" pub-id-type="custom">anatomy-509</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Направления дифференцировки аллогенных мультипотентных стромальных клеток в регенерирующей печени</article-title><trans-title-group xml:lang="en"><trans-title>Directions of allogeneic multipotent stromal cells differentiation in the regenerating liver</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ельчанинов</surname><given-names>Андрей Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>El'chaninov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">elchandrey@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фатхудинов</surname><given-names>Тимур Хайсамудинович</given-names></name><name name-style="western" xml:lang="en"><surname>Fatkhudinov</surname><given-names>T. Kh.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арутюнян</surname><given-names>Ирина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Arutyunyan</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макаров</surname><given-names>Андрей Витальевич</given-names></name><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лохонина</surname><given-names>Анастасия Викторовна</given-names></name><name name-style="western" xml:lang="en"><surname>Lokhonina</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Еремина</surname><given-names>Ирина Здиславовна</given-names></name><name name-style="western" xml:lang="en"><surname>Eremina</surname><given-names>I. Z.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бичерова</surname><given-names>Ирина Анатольевна</given-names></name><name name-style="western" xml:lang="en"><surname>Bicherova</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Большакова</surname><given-names>Галина Борисовна</given-names></name><name name-style="western" xml:lang="en"><surname>Bol'shakova</surname><given-names>G. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова Минздрава России»</institution></aff><aff xml:lang="en"><institution>V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова Минздрава России»; ФГБНУ «Научно-исследовательский институт морфологии человека»</institution></aff><aff xml:lang="en"><institution>V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia; Research Institute of Human Morphology, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова Минздрава России»; ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff><aff xml:lang="en"><institution>V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia; Pirogov Russian National Research Medical University, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова Минздрава России»; ФГАОУ ВО «Российский университет дружбы народов»</institution></aff><aff xml:lang="en"><institution>V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology, Moscow, Russia; The Peoples' Friendship University of Russia, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов»</institution></aff><aff xml:lang="en"><institution>The Peoples' Friendship University of Russia, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University, Moscow, Russia</institution></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт морфологии человека»</institution></aff><aff xml:lang="en"><institution>Research Institute of Human Morphology, Moscow, Russia</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>22</day><month>01</month><year>2018</year></pub-date><volume>6</volume><issue>4</issue><fpage>15</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ельчанинов А.В., Фатхудинов Т.Х., Арутюнян И.В., Макаров А.В., Лохонина А.В., Еремина И.З., Бичерова И.А., Большакова Г.Б., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Ельчанинов А.В., Фатхудинов Т.Х., Арутюнян И.В., Макаров А.В., Лохонина А.В., Еремина И.З., Бичерова И.А., Большакова Г.Б.</copyright-holder><copyright-holder xml:lang="en">El'chaninov A.V., Fatkhudinov T.K., Arutyunyan I.V., Makarov A.V., Lokhonina A.V., Eremina I.Z., Bicherova I.A., Bol'shakova G.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://anatomy.elpub.ru/jour/article/view/509">https://anatomy.elpub.ru/jour/article/view/509</self-uri><abstract><p>Цель работы - изучить заместительный механизм терапевтической активности мультипотентных стромальных клеток пупочного канатика на модели регенерации печени крыс после субтотальной резекции органа. Материал и методы . Работа выполнена на крысах аутбредного стока Спрейг-Доули, у которых воспроизведена модель регенерации печени после субтотальной резекции - удаление 80% паренхимы. Мультипотентные стромальные клетки выделяли из стромы пупочного канатика крысы методом эксплантов, подтверждали их принадлежность к указанному типу, метили витальным красителем РКН26 и трансплантировали в печень непосредственно после резекции. Далее животных выводили из эксперимента на 1-, 7- и 10-е сутки после субтотальной резекции. Печень удаляли, замораживали при -80°С и готовили криосрезы. Полученные срезы окрашивали первыми антителами к соответствующему белку-маркеру и вторыми антителами, несущими флуоресцентную метку, ядра докрашивали DAPI. Результаты. На всех сроках исследования в регенерирующей печени обнаруживались клетки, несущие мембранную метку РКН26. При изучении направления дифференцировки было обнаружено, что введенные клетки не встраивались в балки гепатоцитов или стенку желчных протоков, а также не экспрессировали маркер гепатоцитов - цитокератин 18, холангиоцитов - цитокератин 19. Трансплантированные клетки располагались в соединительной ткани вокруг сосудов, при этом введенные клетки не экспрессировали маркер гладких миоцитов - альфа гладкомышечный актин, однако в единичных клетках визуализировался маркер эндотелиоцитов CD31. Выводы. Дифференцировка мультипотентных стромальных клеток не является ведущим механизмом активности клеток в условиях регенерации печени после субтотальной резекции.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to study the replacement mechanism of the therapeutic activity of umbilical multipotent stromal cells in a model of liver regeneration after subtotal resection in rats. Material and methods. The work was performed on rats of outbred Sprayg-Dowley rats, which reproduced the model of liver regeneration after subtotal resection - removal of 80% of the liver mass. Cell cultures were obtained from rat umbilical cord intervascular tissue by explant culture. Their identity as multipotent stromal cells was confirmed by observations of characteristic morphology, adhesive properties, robust clonogenic growth on untreated plastic, specific surface antigen expression profile, and differentiation capacities to the osteogenic, chondrogenic and adipogenic phenotype. The multipotent stromal cells of the third passage were labeled with PKH26 transplanted into the regenerating liver during liver subtotal resection. Differentiation of the transplanted cells was subsequently evaluated with fluorescence. Results. Multipotent stromal cells differentiation was assessed with antibodies to hepatocyte-specific marker cytokeratin 18 (CK18), cholangiocyte-specific protein CK19, smooth muscle cell-specific protein α-SMA, the endothelial cell marker CD31, or the active fibroblast marker FAPα. It was shown that the injected cells did not express the hepatocyte marker - cytokeratin 18, cholangiocyte marker - cytokeratin 19, as well as smooth muscle cells - alpha smooth muscle actin, single cells expressed endothelial cells marker - CD31. Conclusions. Thus, the differentiation of multipotent stromal cells is not the leading mechanism of cell activity in conditions of liver regeneration after subtotal resection.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>печень</kwd><kwd>регенерация</kwd><kwd>мультипотентные стромальные клетки</kwd><kwd>liver</kwd><kwd>regeneration</kwd><kwd>multipotent stromal cells</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ельчанинов А. В., Володина М. А., Арутюнян И. В. и др. Влияние мультипотентных стромальных клеток на функцию митохондрий клеток регенерирующей печени. Клеточные технологии в биологии и медицине. 2014; 4: 253-259.</mixed-citation><mixed-citation xml:lang="en">Ельчанинов А. В., Володина М. А., Арутюнян И. В. и др. Влияние мультипотентных стромальных клеток на функцию митохондрий клеток регенерирующей печени. Клеточные технологии в биологии и медицине. 2014; 4: 253-259.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Котельникова Л. П., Будянская И. М. Профилактика и лечение осложнений после резекции печени. Вестник хирургии им. И.И. Грекова. 2012; 3(171): 67-71.</mixed-citation><mixed-citation xml:lang="en">Котельникова Л. П., Будянская И. М. Профилактика и лечение осложнений после резекции печени. Вестник хирургии им. И.И. Грекова. 2012; 3(171): 67-71.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Arutyunyan I., Elchaninov A., Fatkhudinov T., et al. Elimination of allogeneic multipotent stromal cells by host macrophages in different models of regeneration. Int. J. Clin. Exp. Pathol. 2015; 8(5): 4469-80.</mixed-citation><mixed-citation xml:lang="en">Arutyunyan I., Elchaninov A., Fatkhudinov T., et al. Elimination of allogeneic multipotent stromal cells by host macrophages in different models of regeneration. Int. J. Clin. Exp. Pathol. 2015; 8(5): 4469-80.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ayatollahi M., Hesami Z., Jamshidzadeh A., Gramizadeh B. Antioxidant Effects of Bone Marrow Mesenchymal Stem Cell against Carbon Tetrachloride-Induced Oxidative Damage in Rat Livers. Int J Organ Transplant. Med. 2014;5(4):166-73.</mixed-citation><mixed-citation xml:lang="en">Ayatollahi M., Hesami Z., Jamshidzadeh A., Gramizadeh B. Antioxidant Effects of Bone Marrow Mesenchymal Stem Cell against Carbon Tetrachloride-Induced Oxidative Damage in Rat Livers. Int J Organ Transplant. Med. 2014;5(4):166-73.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bae S., Park C. W., Son H. K. et al. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br. J. Haematol. 2008;142(5):827-30.</mixed-citation><mixed-citation xml:lang="en">Bae S., Park C. W., Son H. K. et al. Fibroblast activation protein alpha identifies mesenchymal stromal cells from human bone marrow. Br. J. Haematol. 2008;142(5):827-30.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dahm F., Georgiev P., Clavien P. A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am. J. Transplant. 2005; 5(11): 2605-10.</mixed-citation><mixed-citation xml:lang="en">Dahm F., Georgiev P., Clavien P. A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am. J. Transplant. 2005; 5(11): 2605-10.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Darby I. A., Laverdet B., Bonté F., Desmoulière A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014; 7: 301-11. doi: 10.2147/CCID.S50046.</mixed-citation><mixed-citation xml:lang="en">Darby I. A., Laverdet B., Bonté F., Desmoulière A. Fibroblasts and myofibroblasts in wound healing. Clin Cosmet Investig Dermatol. 2014; 7: 301-11. doi: 10.2147/CCID.S50046.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">De Leve L. D. Liver sinusoidal endothelial cells and liver regeneration. J. Clin. Invest. 2013; 123(5): 1861-6.</mixed-citation><mixed-citation xml:lang="en">De Leve L. D. Liver sinusoidal endothelial cells and liver regeneration. J. Clin. Invest. 2013; 123(5): 1861-6.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">di Bonzo L. V., Ferrero I., Cravanzola C., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008; 57(2): 223-31.</mixed-citation><mixed-citation xml:lang="en">di Bonzo L. V., Ferrero I., Cravanzola C., et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008; 57(2): 223-31.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-7.</mixed-citation><mixed-citation xml:lang="en">Dominici M., Le Blanc K., Mueller I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4): 315-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Driskell R. R., Watt F. M. Understanding fibroblast heterogeneity in the skin. Trends Cell Biol. 2015; 25(2): 92-9. doi: 10.1016/j.tcb.2014.10.001</mixed-citation><mixed-citation xml:lang="en">Driskell R. R., Watt F. M. Understanding fibroblast heterogeneity in the skin. Trends Cell Biol. 2015; 25(2): 92-9. doi: 10.1016/j.tcb.2014.10.001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hammond J. S., Guha I. N., Beckingham I. J., Lobo D. N. Prediction, prevention and management of postresection liver failure. Br. J. Surg. 2011; 98(9):1188-200. doi: 10.1002/bjs.7630.</mixed-citation><mixed-citation xml:lang="en">Hammond J. S., Guha I. N., Beckingham I. J., Lobo D. N. Prediction, prevention and management of postresection liver failure. Br. J. Surg. 2011; 98(9):1188-200. doi: 10.1002/bjs.7630.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly T., Huang Y., Simms A. E. et al. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int. Rev. Cell Mol. Biol. 2012; 297: 83-116.</mixed-citation><mixed-citation xml:lang="en">Kelly T., Huang Y., Simms A. E. et al. Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies. Int. Rev. Cell Mol. Biol. 2012; 297: 83-116.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Michalopoulos G. K. Liver regeneration. J. Cell. Physiol. 2007; 213(2): 286-300.</mixed-citation><mixed-citation xml:lang="en">Michalopoulos G. K. Liver regeneration. J. Cell. Physiol. 2007; 213(2): 286-300.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pacini S., Petrini I. Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front. Cell. Dev. Biol. 2014; 2(20).</mixed-citation><mixed-citation xml:lang="en">Pacini S., Petrini I. Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells. Front. Cell. Dev. Biol. 2014; 2(20).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Vittorio O., Jacchetti E., Pacini S. et al. Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction. Integr Biol (Camb). 2013; 5(2): 291-9.</mixed-citation><mixed-citation xml:lang="en">Vittorio O., Jacchetti E., Pacini S. et al. Endothelial differentiation of mesenchymal stromal cells: when traditional biology meets mechanotransduction. Integr Biol (Camb). 2013; 5(2): 291-9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H., Zhao T., Xu F., et al. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease? Cytotherapy. 2013; 0: 1e10</mixed-citation><mixed-citation xml:lang="en">Wang H., Zhao T., Xu F., et al. How important is differentiation in the therapeutic effect of mesenchymal stromal cells in liver disease? Cytotherapy. 2013; 0: 1e10</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Watt S. M., Gullo F., van der Garde M., et. al. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br. Med. Bull. 108, 25-53. doi:10.1093/bmb/ldt031</mixed-citation><mixed-citation xml:lang="en">Watt S. M., Gullo F., van der Garde M., et. al. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br. Med. Bull. 108, 25-53. doi:10.1093/bmb/ldt031</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wu X. B., Tao R., Li D.-L. et al. Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):360-71. Hepatocyte differentiation of mesenchymal stem cells. Pathobiology. 2013; 80: 228-234.</mixed-citation><mixed-citation xml:lang="en">Wu X. B., Tao R., Li D.-L. et al. Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):360-71. Hepatocyte differentiation of mesenchymal stem cells. Pathobiology. 2013; 80: 228-234.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yin L., Zhu Y., Yang J., et al. Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte like cells in vivo and in vitro. Mol. Med. Rep. 2014. doi: 10.3892/mmr.2014.2935.</mixed-citation><mixed-citation xml:lang="en">Yin L., Zhu Y., Yang J., et al. Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte like cells in vivo and in vitro. Mol. Med. Rep. 2014. doi: 10.3892/mmr.2014.2935.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
